Annual ROE
-3.15%
-26.14%-113.70%
December 31, 2024
Summary
- As of February 18, 2025, VRTX annual return on equity is -3.15%, with the most recent change of -26.14% (-113.70%) on December 31, 2024.
- During the last 3 years, VRTX annual ROE has fallen by -28.08% (-112.64%).
- VRTX annual ROE is now -104.87% below its all-time high of 64.74%, reached on December 31, 2018.
Performance
VRTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-3.23%
-0.34%-11.76%
December 31, 2024
Summary
- As of February 18, 2025, VRTX quarterly return on equity is -3.23%, with the most recent change of -0.34% (-11.76%) on December 31, 2024.
- Over the past year, VRTX quarterly ROE has dropped by -26.46% (-113.90%).
- VRTX quarterly ROE is now -104.48% below its all-time high of 72.02%, reached on December 31, 2018.
Performance
VRTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VRTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -113.7% | -113.9% |
| 3 y3 years | -112.6% | -111.0% |
| 5 y5 years | -114.1% | -111.0% |
VRTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -111.4% | at low | -110.5% | at low |
| 5 y | 5-year | -108.6% | at low | -108.0% | at low |
| alltime | all time | -104.9% | +98.3% | -104.5% | +98.9% |
Vertex Pharmaceuticals Incorporated ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -3.15%(-113.7%) | -3.23%(+11.8%) |
| Sep 2024 | - | -2.89%(-2.4%) |
| Jun 2024 | - | -2.96%(-112.2%) |
| Mar 2024 | - | 24.35%(+4.8%) |
| Dec 2023 | 22.99%(-16.9%) | 23.23%(-1.8%) |
| Sep 2023 | - | 23.65%(-3.3%) |
| Jun 2023 | - | 24.46%(-3.6%) |
| Mar 2023 | - | 25.38%(-8.5%) |
| Dec 2022 | 27.67%(+11.0%) | 27.74%(-5.9%) |
| Sep 2022 | - | 29.49%(-4.6%) |
| Jun 2022 | - | 30.91%(+22.9%) |
| Mar 2022 | - | 25.16%(-0.1%) |
| Dec 2021 | 24.93%(-32.1%) | 25.19%(+3.1%) |
| Sep 2021 | - | 24.44%(+4.4%) |
| Jun 2021 | - | 23.42%(-32.5%) |
| Mar 2021 | - | 34.72%(-5.5%) |
| Dec 2020 | 36.71%(+64.1%) | 36.76%(-8.6%) |
| Sep 2020 | - | 40.22%(+17.5%) |
| Jun 2020 | - | 34.23%(+25.0%) |
| Mar 2020 | - | 27.38%(+19.0%) |
| Dec 2019 | 22.37%(-65.4%) | 23.01%(-51.9%) |
| Sep 2019 | - | 47.82%(-14.2%) |
| Jun 2019 | - | 55.72%(-10.9%) |
| Mar 2019 | - | 62.51%(-13.2%) |
| Dec 2018 | 64.74%(+315.3%) | 72.02%(+165.5%) |
| Sep 2018 | - | 27.13%(+41.8%) |
| Jun 2018 | - | 19.13%(+66.3%) |
| Mar 2018 | - | 11.50%(-23.7%) |
| Dec 2017 | 15.59%(-269.1%) | 15.08%(+21.7%) |
| Sep 2017 | - | 12.39%(-30.7%) |
| Jun 2017 | - | 17.88%(+31.4%) |
| Mar 2017 | - | 13.61%(-243.9%) |
| Dec 2016 | -9.22%(-81.9%) | -9.46%(-51.0%) |
| Sep 2016 | - | -19.31%(-22.7%) |
| Jun 2016 | - | -24.99%(-33.3%) |
| Mar 2016 | - | -37.45%(-28.5%) |
| Dec 2015 | -50.81%(-15.6%) | -52.36%(-14.6%) |
| Sep 2015 | - | -61.33%(-8.6%) |
| Jun 2015 | - | -67.11%(+7.7%) |
| Mar 2015 | - | -62.33%(+1.5%) |
| Dec 2014 | -60.23%(+72.7%) | -61.43%(+51.0%) |
| Sep 2014 | - | -40.68%(+15.8%) |
| Jun 2014 | - | -35.12%(+23.2%) |
| Mar 2014 | - | -28.50%(-17.4%) |
| Dec 2013 | -34.87%(+245.9%) | -34.52%(-22.4%) |
| Sep 2013 | - | -44.49%(+9.7%) |
| Jun 2013 | - | -40.55%(-8.0%) |
| Mar 2013 | - | -44.07%(+372.3%) |
| Dec 2012 | -10.08%(-344.1%) | -9.33%(-177.0%) |
| Sep 2012 | - | 12.11%(-73.4%) |
| Jun 2012 | - | 45.58%(+10.6%) |
| Mar 2012 | - | 41.22%(+737.8%) |
| Dec 2011 | 4.13%(-104.4%) | 4.92%(-108.7%) |
| Sep 2011 | - | -56.76%(-56.7%) |
| Jun 2011 | - | -131.02%(+15.1%) |
| Mar 2011 | - | -113.79%(+22.7%) |
| Dec 2010 | -94.31%(-2.0%) | -92.75%(+5.6%) |
| Sep 2010 | - | -87.81%(+10.9%) |
| Jun 2010 | - | -79.20%(+1.5%) |
| Mar 2010 | - | -78.03%(-17.9%) |
| Dec 2009 | -96.19%(-46.6%) | -95.00%(-20.1%) |
| Sep 2009 | - | -118.83%(-11.2%) |
| Jun 2009 | - | -133.87%(-6.4%) |
| Mar 2009 | - | -143.05%(-12.6%) |
| Dec 2008 | -180.27%(+79.0%) | -163.74%(+21.6%) |
| Sep 2008 | - | -134.66%(+10.6%) |
| Jun 2008 | - | -121.71%(+9.1%) |
| Mar 2008 | - | -111.52%(+15.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | -100.69%(+81.3%) | -96.61%(+31.3%) |
| Sep 2007 | - | -73.59%(+11.6%) |
| Jun 2007 | - | -65.96%(+6.8%) |
| Mar 2007 | - | -61.76%(-0.9%) |
| Dec 2006 | -55.53%(-62.5%) | -62.29%(-26.3%) |
| Sep 2006 | - | -84.49%(-37.8%) |
| Jun 2006 | - | -135.86%(-6.3%) |
| Mar 2006 | - | -145.02%(-25.5%) |
| Dec 2005 | -148.15%(+1.7%) | -194.70%(-33.1%) |
| Sep 2005 | - | -290.95%(+16.4%) |
| Jun 2005 | - | -249.98%(+8.1%) |
| Mar 2005 | - | -231.28%(+58.6%) |
| Dec 2004 | -145.65%(+111.5%) | -145.83%(+35.8%) |
| Sep 2004 | - | -107.40%(+1.8%) |
| Jun 2004 | - | -105.55%(+27.9%) |
| Mar 2004 | - | -82.50%(+63.9%) |
| Dec 2003 | -68.87%(+170.7%) | -50.33%(+21.3%) |
| Sep 2003 | - | -41.48%(+77.2%) |
| Jun 2003 | - | -23.41%(+47.2%) |
| Mar 2003 | - | -15.90%(-37.1%) |
| Dec 2002 | -25.44%(+90.0%) | -25.27%(+42.3%) |
| Sep 2002 | - | -17.76%(+36.3%) |
| Jun 2002 | - | -13.03%(+15.8%) |
| Mar 2002 | - | -11.25%(+41.0%) |
| Dec 2001 | -13.39%(+39.3%) | -7.98%(-18.2%) |
| Sep 2001 | - | -9.75%(-35.0%) |
| Jun 2001 | - | -15.01%(+70.4%) |
| Mar 2001 | - | -8.81%(-34.9%) |
| Dec 2000 | -9.61%(-46.6%) | -13.54%(-1.0%) |
| Sep 2000 | - | -13.68%(+55.3%) |
| Jun 2000 | - | -8.81%(-55.5%) |
| Mar 2000 | - | -19.78%(+7.0%) |
| Dec 1999 | -18.00%(+42.0%) | -18.49%(-22.5%) |
| Sep 1999 | - | -23.86%(+33.5%) |
| Jun 1999 | - | -17.87%(+6.7%) |
| Mar 1999 | - | -16.75%(+32.5%) |
| Dec 1998 | -12.68%(+30.3%) | -12.64%(+24.5%) |
| Sep 1998 | - | -10.15%(-9.9%) |
| Jun 1998 | - | -11.27%(+39.0%) |
| Mar 1998 | - | -8.11%(+1.9%) |
| Dec 1997 | -9.73%(-73.7%) | -7.96%(+3.6%) |
| Sep 1997 | - | -7.68%(-21.6%) |
| Jun 1997 | - | -9.80%(-65.2%) |
| Mar 1997 | - | -28.17%(-31.0%) |
| Dec 1996 | -37.02%(+64.2%) | -40.82%(-1.6%) |
| Sep 1996 | - | -41.49%(-10.7%) |
| Jun 1996 | - | -46.48%(+70.0%) |
| Mar 1996 | - | -27.34%(+20.0%) |
| Dec 1995 | -22.54%(-0.7%) | -22.78%(-14.4%) |
| Sep 1995 | - | -26.61%(+16.5%) |
| Jun 1995 | - | -22.84%(+21.4%) |
| Mar 1995 | - | -18.82%(-2.5%) |
| Dec 1994 | -22.71%(-630.6%) | -19.30%(+284.5%) |
| Sep 1994 | - | -5.02%(+25.2%) |
| Jun 1994 | - | -4.01%(-211.7%) |
| Mar 1994 | - | 3.59%(-17.7%) |
| Dec 1993 | 4.28%(-124.2%) | 4.36%(-119.7%) |
| Sep 1993 | - | -22.11%(+9.5%) |
| Jun 1993 | - | -20.20%(-7.9%) |
| Mar 1993 | - | -21.94%(+26.3%) |
| Dec 1992 | -17.69%(-0.5%) | -17.37%(+12.0%) |
| Sep 1992 | - | -15.51%(-6.0%) |
| Jun 1992 | - | -16.50%(-17.0%) |
| Mar 1992 | - | -19.87%(-14.5%) |
| Dec 1991 | -17.77%(-78.5%) | -23.23%(-43.7%) |
| Sep 1991 | - | -41.29%(-66.5%) |
| Jun 1991 | - | -123.08%(+42.2%) |
| Mar 1991 | - | -86.54%(+4.7%) |
| Dec 1990 | -82.69% | -82.69% |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual return on equity?
- What is the all time high annual ROE for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual ROE year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly return on equity?
- What is the all time high quarterly ROE for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly ROE year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual return on equity?
The current annual ROE of VRTX is -3.15%
What is the all time high annual ROE for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual return on equity is 64.74%
What is Vertex Pharmaceuticals Incorporated annual ROE year-on-year change?
Over the past year, VRTX annual return on equity has changed by -26.14% (-113.70%)
What is Vertex Pharmaceuticals Incorporated quarterly return on equity?
The current quarterly ROE of VRTX is -3.23%
What is the all time high quarterly ROE for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly return on equity is 72.02%
What is Vertex Pharmaceuticals Incorporated quarterly ROE year-on-year change?
Over the past year, VRTX quarterly return on equity has changed by -26.46% (-113.90%)